tiprankstipranks
Trending News
More News >
Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh (AU:DOC)
ASX:DOC
Australian Market

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh (DOC) AI Stock Analysis

Compare
4 Followers

Top Page

AU:DOC

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh

(Sydney:DOC)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 5.2)
Rating:52Neutral
Price Target:
AU$0.14
▲(0.71% Upside)
Action:ReiteratedDate:03/07/26
The score is driven primarily by improving financial performance (profitability and free cash flow turnaround) but is held back materially by balance-sheet leverage risk. Technically, the stock is in a weak downtrend below key moving averages, and valuation appears only moderate given the risk profile.
Positive Factors
Cash generation turnaround
The move to sustained positive operating and free cash flow in 2025 represents a structural improvement in cash conversion. Durable FCF provides internal funding for growth, de-leveraging or strategic investment, reducing reliance on external capital if maintained over coming quarters.
Return to profitability
Restoring positive net and operating margins shows the business model can reach profitability at scale. Even with thin margins, sustained profitability supports strategic flexibility, reinvestment and credibility with partners and payors if revenue trends stabilize.
Scalable telehealth platform
A digital healthcare platform with a clinical network benefits from structural tailwinds in telehealth adoption and potential recurring enterprise contracts. Platform scale can drive marginal cost advantages and expand services, creating a durable growth runway if execution continues.
Negative Factors
High leverage
Extremely elevated debt relative to equity leaves the capital structure fragile and raises refinancing, interest and covenant risks. High leverage constrains strategic choices, limits ability to absorb operating hiccups and makes sustained recovery dependent on continued cash generation.
Thin & deteriorating margins
Declining gross margin and still-narrow operating profits reduce the firm's buffer against rising costs or pricing pressure. Persistently thin margins make long-term profitability sensitive to modest revenue or cost swings and limit capacity to fund growth internally.
Uneven revenue & cash volatility
Historic revenue and cash-flow volatility undermines predictability of the recovery. Inconsistent top-line growth and prior negative FCF episodes raise execution risk; the company must sustain multiple quarters of improvement to lock in a durable recovery.

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh (DOC) vs. iShares MSCI Australia ETF (EWA)

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Business Overview & Revenue Model

Company DescriptionDoctor Care Anywhere Group PLC, together with its subsidiaries, provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland. It offers services in the areas of appointments, patient records, prescriptions, referrals and fit notes, service improvements, and virtual GP consultations in the form of video and phone. The company provides treatments for allergies, bites and stings, cold and flu, headaches and migraines, joint pains, lifestyle support, mental and sexual health, skin conditions, and stomach and digestive problems, as well as offers virtual healthcare, technology platform licensing, and digital design services. It serves medical insurers, employers, retailers, healthcare providers, and direct sales to the public. The company was incorporated in 2013 and is headquartered in London, the United Kingdom.
How the Company Makes MoneyDoctor Care Anywhere generates revenue primarily through its subscription-based model, where patients pay for access to telehealth services and consultations. Key revenue streams include fees from individual consultations, monthly or annual subscriptions for ongoing health services, and partnerships with employers and insurance companies that offer its services as part of employee health benefits. Additionally, the company may earn income from partnerships with healthcare providers and pharmaceutical companies for integrated care solutions and prescription fulfillment services, which contribute to its overall earnings.

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Financial Statement Overview

Summary
Operations improved in 2025 with a return to profitability and strong free cash flow, but the balance sheet is a major constraint (very high debt-to-equity and previously negative equity). Revenue growth is uneven and margins remain thin, keeping the financial score mid-range.
Income Statement
62
Positive
Profitability has improved materially: the company moved from large losses in 2021–2024 to positive earnings in 2025 (net profit margin ~3.0% and EBIT margin ~4.5%). Revenue has been relatively stable recently (2025 revenue slightly down vs. 2024), and the gross margin fell sharply in 2025 versus 2024, suggesting either pricing pressure or higher cost of service. Overall, the trajectory is positive (returning to profitability), but margins remain thin and the revenue growth profile looks uneven.
Balance Sheet
28
Negative
Leverage is a key weakness. Total debt is high relative to equity in 2025 (debt-to-equity ~10.2x), and equity was negative in 2024, highlighting prior balance-sheet strain. While total assets have grown versus 2024, the capital structure still looks fragile and leaves limited cushion if operating performance softens.
Cash Flow
74
Positive
Cash generation strengthened significantly in 2025: operating cash flow (~4.9M) and free cash flow (~4.9M) were solid and sharply higher than 2024, indicating improved cash conversion and better underlying operations. However, prior years show meaningful volatility, including materially negative operating and free cash flow in 2021–2023, so consistency remains a watch item.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue38.43M39.33M38.46M29.31M24.96M
Gross Profit14.12M22.42M17.69M13.42M10.40M
EBITDA4.21M-2.15M-5.78M-16.95M-18.92M
Net Income1.17M-6.29M-10.05M-22.03M-20.22M
Balance Sheet
Total Assets17.18M14.99M19.61M22.01M19.69M
Cash, Cash Equivalents and Short-Term Investments6.56M5.29M8.10M5.41M17.07M
Total Debt10.39M8.27M11.00M1.59M1.35M
Total Liabilities16.16M15.64M17.27M9.72M3.86M
Stockholders Equity1.02M-645.00K2.33M12.29M15.82M
Cash Flow
Free Cash Flow4.85M347.00K-8.67M-24.38M-10.10M
Operating Cash Flow4.92M353.00K-6.34M-22.03M-8.65M
Investing Cash Flow-2.29M-1.65M-2.24M-2.34M-2.42M
Financing Cash Flow-428.87K-332.00K9.32M5.90M-611.00K

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.14
Price Trends
50DMA
0.15
Negative
100DMA
0.15
Negative
200DMA
0.14
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
40.11
Neutral
STOCH
39.80
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DOC, the sentiment is Negative. The current price of 0.14 is below the 20-day moving average (MA) of 0.16, below the 50-day MA of 0.15, and below the 200-day MA of 0.14, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 40.11 is Neutral, neither overbought nor oversold. The STOCH value of 39.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:DOC.

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
52
Neutral
AU$49.50M24.60250.55%-6.86%51.88%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
49
Neutral
AU$34.68M-4.21-52.26%-36.68%79.41%
45
Neutral
AU$34.49M-3.13-1009.84%25.98%22.10%
43
Neutral
AU$71.03M-6.64-59.96%
42
Neutral
AU$4.12M-1.9820.02%-9.90%34.07%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:DOC
Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh
0.14
0.05
50.00%
AU:GLH
Global Health Limited
0.07
-0.04
-36.36%
AU:SHG
Singular Health Group Ltd
0.23
-0.02
-10.00%
AU:EMD
Emyria Ltd
0.04
0.01
38.71%
AU:PCK
PainChek Ltd
0.17
-0.21
-55.41%

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Corporate Events

Doctor Care Anywhere Sets Date for 2026 AGM and Highlights Growth-Focused Telehealth Strategy
Mar 5, 2026

Doctor Care Anywhere Group PLC has scheduled its 2026 Annual General Meeting for Tuesday, 28 April 2026, in line with ASX listing requirements and under the authority of its board and company secretary. The company is also directing investors to its interactive online hub and news alert service, reinforcing engagement with shareholders as it pursues a growth strategy built on digital telehealth, partnerships, and data-led healthcare delivery.

The AGM date announcement provides clarity for investors and other stakeholders on the company’s governance calendar and engagement opportunities. By highlighting its strategic focus on scaling its telehealth platform and deepening partnerships with insurers and corporates, Doctor Care Anywhere underlines its ambition to strengthen its position in the UK private telehealth market and drive sustained value creation.

The most recent analyst rating on (AU:DOC) stock is a Hold with a A$0.20 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Delivers First Annual Profit as Digital Health Platform Expands
Feb 24, 2026

Doctor Care Anywhere reported a strong turnaround for 2025, delivering its first positive earnings per share as revenue rose 6.5% to £38 million and underlying EBITDA climbed to £5.3 million, a 13.9% margin. Net profit reached £1.2 million, contribution margin improved to 43.5%, and cash generation of £2.2 million lifted year-end cash to £6.6 million, with management reaffirming medium-term ambitions to double revenue over three to five years and sustain a 15% EBITDA margin.

Operationally, the group broadened its platform by adding mental health practitioners and physiotherapists, which improved patient access and reduced cost to serve, while activated lives increased 7.9% to about 1.28 million. Overall consultation volumes fell 4% due to the prior closure of a secondary care pathway, but excluding that impact they were flat and returned to 3.4% growth in the second half, indicating strengthening demand from new products and clients and a firmer competitive footing in digital healthcare.

The most recent analyst rating on (AU:DOC) stock is a Hold with a A$0.16 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Posts Strong Cashflow and Rising Patient Engagement in Q4 2025
Jan 28, 2026

Doctor Care Anywhere reported renewed consultation growth in the second half of 2025, with volumes up 3.4% and consistently above 2024 levels since May, supported by a 7.9% year-on-year increase in activated lives to 1.3 million and a rise in repeat patients to 75% of consultations, indicating stronger engagement and loyalty despite seasonal quarter-on-quarter softness. The company delivered its third consecutive quarter of positive cash generation, with £1.1m net operating and investing cash inflow in Q4 and a strengthened cash balance of £6.6m, while advancing digital treatment pilots in musculoskeletal, mental health and dermatology, developing new propositions in corporate weight management and preventative health, and reaffirming medium-term guidance to double revenue over three to five years and target a 15% EBITDA margin, underscoring confidence in its growth trajectory and investment capacity.

The most recent analyst rating on (AU:DOC) stock is a Sell with a A$0.13 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Sets Date for Q4 2025 Activity and Cash Flow Update
Jan 23, 2026

Doctor Care Anywhere Group PLC has announced that it will release its Appendix 4C quarterly cash flow and activity report for the fourth quarter of 2025 on 29 January 2026, providing an update on the company’s recent operational and financial performance. The timing of the release signals continued transparency for investors and other stakeholders as the telehealth provider executes its growth strategy in a competitive digital healthcare market, with the forthcoming report likely to inform assessments of its progress in scaling services and deepening partnerships.

The most recent analyst rating on (AU:DOC) stock is a Sell with a A$0.13 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Director Increases Stake via On-Market Purchase
Jan 14, 2026

Doctor Care Anywhere Group PLC has disclosed that director John Stier increased his direct holding in the company by acquiring 500,000 ordinary fully paid CHESS Depositary Interests on-market, lifting his stake from 3.5 million to 4 million securities at a total cost of AUD 73,183. The trade, placed under a standing instruction during an open trading window and approved by the board, was executed on 8 January 2026 during a closed period due to low market liquidity and holiday-related delays, with the company stating that Stier did not possess any undisclosed price-sensitive information at the time, underscoring compliance with governance and insider trading rules.

The most recent analyst rating on (AU:DOC) stock is a Sell with a A$0.13 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 07, 2026